Download Saracen Growth Fund February Commentary February proved to be

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Special-purpose acquisition company wikipedia , lookup

Leveraged buyout wikipedia , lookup

Short (finance) wikipedia , lookup

Market (economics) wikipedia , lookup

Investor-state dispute settlement wikipedia , lookup

Private equity secondary market wikipedia , lookup

Corporate venture capital wikipedia , lookup

Mark-to-market accounting wikipedia , lookup

Stock trader wikipedia , lookup

Private money investing wikipedia , lookup

International investment agreement wikipedia , lookup

Mutual fund wikipedia , lookup

Early history of private equity wikipedia , lookup

Fund governance wikipedia , lookup

Socially responsible investing wikipedia , lookup

Investment banking wikipedia , lookup

History of investment banking in the United States wikipedia , lookup

Environmental, social and corporate governance wikipedia , lookup

Investment management wikipedia , lookup

Transcript
Saracen Growth Fund
February Commentary
February proved to be a busy month for Saracen Growth Fund with the addition of three new stocks.
We bought DX Group, Morgan Advanced Materials and First Group over the course of the month
and the rationale for buying each of the companies is given below.
DX plc is a leading independent mail, parcels and logistics network operator in the UK and Ireland
delivering in excess of 200 million items annually. The company has a large exposure to the fast
growing parcels market (over 50% of revenue is derived from the Freight and Parcels division), which
is forecast by PWC to increase at between 4-5% annually. The company was floated on the AIM
market in February and was heavily oversubscribed by institutions. As regular readers of our
commentary will know, we shy away from investing in IPO’s unless they are either demonstrably
cheaper than existing peers or offer something different. DX was floated on a single digit P/E for
2014 and a yield of 6% for its first full year in 2015. This appears to offer very good value.
Morgan Advanced Materials is a world leader in its chosen field - it uses a wide range of specialist,
high specification materials which are engineered into products which then deliver enhanced
performance, often under extreme conditions. The company’s products go into a wide range of end
markets such as energy, electronics, transportation and healthcare. Although the company
produces a variety of different products for industrial and geographical markets, there are unifying
themes. It specialises in bringing science and engineering expertise to meet demanding technical
requirements and looks to position itself in growth markets. The company works with their
customers at every stage from concept and feasibility to prototyping and full production.
Revenue prospects for the group look promising as management has moved the company into faster
growing areas such as transport, healthcare and industrials, over the course of the last six years.
Historically, the company has grown 1.5 - 3 times faster than GDP - consensus expectations for GDP
growth are 3% per annum for the next 2 years. Management has a goal of achieving mid-teens
operating margin by 2015 and are doing a reasonable job, having earned margins of 12.4% during,
what they believe to be, a low point in the cycle.
The stock was purchased on a valuation of only 12x 2013 earnings which we felt was incredibly low
for a company which has transformed itself over the last six years into a much higher quality, less
cyclical business.
Our final purchase in February was First Group, a leading transport operator in the UK and North
America. First Group has five main operating divisions comprising rail and bus operations and is
diversified by geography and customer base.
First Group shares have nosedived since buying Laidlaw of the US at the top of the market and have
fallen from 800p to 140p today (post a 3 for 2 rights issues at 85p). A combination of an
overstretched balance sheet, poor strategy and an unaffordable dividend policy resulted in capital
expenditure being cut. This company is most definitely a ‘turnaround situation’. Management has
begun turning the business around (rebased UK bus prices, increasing capex to a sensible level from
a significantly under invested position and winning market share) and on our internal forecasts we
believe earnings will more than double over the next five years. In addition, it is likely the dividend
will be reinstated in two years’ time.
Craig Yeaman
Disclaimer
This document contains information relating to Saracen Fund Managers Ltd and Saracen Investment Funds ICVC (‘the Company’).
Saracen Fund Managers Ltd is authorised and regulated by the Financial Conduct Authority (‘FCA’).
This document is issued and approved by Saracen Fund Managers Ltd (‘SFM’) for communication in the United Kingdom only to persons of
a kind to whom this document may, for the time being, be communicated by SFM by virtue of the Financial Services Markets Act 2000
(‘FSMA’) (Promotion of Collective Investment Schemes) (Exemptions) (Amendment) Order 2005, rule 3.11.2 and annex 5 of the Conduct of
Business Rules of the FCA or any other exemption to section 238 of the FSMA (‘Permitted Recipients’).
The Company is an open-ended umbrella fund incorporated as a variable capital investment company in Scotland, under registration
number 180545 and authorised by the FSA pursuant to Part XIII of the Companies Act 1990. SFM acts as an Investment Manager of the
Company.
The distribution of this document in certain jurisdictions may be restricted by law, therefore, people into whose possession this document
comes should inform themselves about and observe any such restrictions. Any such distribution could result in a violation of the law of
such jurisdiction.
Investment in the Company should be considered high risk. Past performance should not be seen as an indication of future performance.
The value of an investment in shares of the Company and any income derived from them can go down as well as up and may be subject to
sudden and substantial falls. An investor may not be able to get back the amount invested and the loss on realisation may be very high
and could result in a substantial or complete loss of the investment. In addition, an investor who realises shares in the Company after a
short period may not realise the amount originally invested as a result of charges made on the issue and/or redemption of shares. The
value of shares for the purpose of purchases may differ from their value for the purpose of redemptions.